News
On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...
Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer reflected on. When asked about the stock during the ...
PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...
Roche (RHHBY) plans direct-to-patient drug sales in the U.S. to avoid the influence from pharmacy benefit managers in product ...
As the relentless march of aging make my knee and shoulder sore, as my lenses cloud and the upper range of my hearing ...
For many seniors living in the U.S. Virgin Islands, the cost of managing chronic illness can be overwhelming. A new ...
Pfizer is on the brink of a major rebound, transitioning focus to oncology and potential blockbuster drugs after a sharp drop in COVID-related revenues. Pfizer’s stock has plummeted over 50% in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results